Ewa Brzozowska

Ewa Brzozowska

Auto-generated profile, based on publicly available information

Ewa Brzozowska

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2018 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
MSMarta Sochocka
Marta Sochocka
Katarzyna Donskow-ŁysoniewskaKatarzyna Donskow-Łysoniewska
Katarzyna Donskow-Łysoniewska
BDBreno Diniz
Breno Diniz
DKDonata Kurpas
Donata Kurpas
EBEwa Brzozowska
Ewa Brzozowska
Jerzy LeszekJerzy Leszek
Jerzy Leszek
One of the most important scientific discoveries of recent years was the disclosure that the intestinal microflora takes part in bidirectional communication between the gut and the brain. Scientists suggest that human gut microflora may even act as the “second brain” and be responsible for neurodegenerative disorders like Alzheimer’s disease (AD). Although human-associated microbial communities are generally stable, they can be altered by common human actions and experiences. Enteric bacteria, commensal, and pathogenic microorganisms, may have a major impact on immune system, brain development, and behavior, as they are able to produce several neurotransmitters and neuromodulators like serotonin, kynurenine, catecholamine, etc., as well as amyloids. However, brain destructive mechanisms, that can lead to dementia and AD, start with the intestinal microbiome dysbiosis, development of local and systemic inflammation, and dysregulation of the gut-brain axis. Increased permeability of the gut epithelial barrier results in invasion of different bacteria, viruses, and their neuroactive products that support neuroinflammatory reactions in the brain. It seems that, inflammatory-infectious hypothesis of AD, with the great role of the gut microbiome, starts to gently push into the shadow the amyloid cascade hypothesis that has dominated for decades. It is strongly postulated that AD may begin in the gut, and is closely related to the imbalance of gut microbiota. This is promising area for therapeutic intervention. Modulation of gut microbiota through personalized diet or beneficial microbiota intervention, alter microbial partners and their products including amyloid protein, will probably become a new treatment for AD.

14 February 2017 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
FAFairoz Al-Wrafy
Fairoz Al-Wrafy
EBEwa Brzozowska
Ewa Brzozowska
Sabina GórskaSabina Górska
Sabina Górska
AGAndrzej Gamian
Andrzej Gamian
Pseudomonas aeruginosa is an opportunistic pathogen that can cause several acute and chronic infections in humans, and it has become an important cause of nosocomial infections and antibiotic resistance. Biofilm represents an important virulence factor for these bacteria, plays a role in P. aeruginosa infections and avoidance of immune defence mechanisms, and has the ability to protect the bacteria from antibiotics. Alginate, Psl and Pel, three exopolysaccharides, are the main components in biofilm matrix, with many biological functions attributed to them, especially with respect to the protection of the bacterial cell from antibiotics and the immune system. Pseudomonas infections, biofilm formation and development of resistance to antibiotics all require better understanding to achieve the best results using alternative treatment with phage therapy. This review describes the P. aeruginosa pathogenicity and virulence factors with a special focus on the biofilm and its role in infection and resistance to antibiotics and summarizes phage therapy as an alternative approach in treatment of P. aeruginosa infections.

1 May 2015 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
EBEwa Brzozowska
Ewa Brzozowska
Mateusz SmietanaMateusz Smietana
Mateusz Smietana
MKMarcin Koba
Marcin Koba
Sabina GórskaSabina Górska
Sabina Górska
KPKrzysztof Jakub Pawlik
Krzysztof Jakub Pawlik
WBWojtek J. Bock
Wojtek J. Bock

24 March 2015 in Optics Express
Verified
Journal Article
Open access
PDF file
Mateusz SmietanaMateusz Smietana
Mateusz Smietana
MKMarcin Koba
Marcin Koba
EBEwa Brzozowska
Ewa Brzozowska
KKKrzysztof Krogulski
Krzysztof Krogulski
JNJakub Nakonieczny
Jakub Nakonieczny
WBWojtek J. Bock
Wojtek J. Bock
In this paper, we discuss an impact of thin titanium dioxide (TiO2) coatings on refractive index (RI) sensitivity and biofunctionalization of long-period gratings (LPGs). The TiO2 overlays on the LPG surfaces have been obtained using atomic layer deposition (ALD) method. This method allows for a deposition of conformal, thickness-controlled, with well-defined optical properties, and high-RI thin films which are highly desired for optical fiber sensors. It has been found that for LPGs working at a dispersion turning point of higher order cladding modes only tens of nanometers of TiO2 overlay thickness allow to obtain cladding mode transition effect, and thus significant improvement of RI sensitivity. When the TiO2 overlay thickness reaches 70 nm, it is possible to obtain RI sensitivity exceeding 6200 nm/RIU in RI range where label-free sensors operate. Moreover, LPGs with TiO2-enhanced RI sensitivity have shown improved sensitivity to bacteria endotoxin (E. coli B lipopolysaccharide) detection, when TiO2 surface is functionalized with endotoxin binding protein (adhesin) of T4 bacteriophage.

1 May 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
MPMonika Piestrzyńska
Monika Piestrzyńska
MDMagdalena Dominik
Magdalena Dominik
KKKamil Kosiel
Kamil Kosiel
MJMarta Janczuk-Richter
Marta Janczuk-Richter
KSKatarzyna Szot-Karpińska
Katarzyna Szot-Karpińska
Mateusz SmietanaMateusz Smietana
Mateusz Smietana

21 April 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
KFKarolina Filik
Karolina Filik
BSBożena Szermer-Olearnik
Bożena Szermer-Olearnik
SOSabina Oleksy
Sabina Oleksy
JBJan Brykała
Jan Brykała
EBEwa Brzozowska
Ewa Brzozowska
In recent years, a number of bacterial detection methods have been developed to replace time-consuming culture methods. One interesting approach is to mobilize the ability of phage tail proteins to recognize and bind to bacterial hosts. In this paper, the authors provide an overview of the current methodologies in which phage proteins play major roles in detecting pathogenic bacteria. Authors focus on proteins capable of recognizing highly pathogenic strains, such as Acinetobacter baumannii, Campylobacter spp., Yersinia pestis, Pseudomonas aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Enterococcus spp., Salmonella spp., and Shigella. These pathogens may be diagnosed by capture-based detection methods involving the use of phage protein-coated nanoparticles, ELISA (enzyme-linked immunosorbent assay)-based methods, or biosensors. The reviewed studies show that phage proteins are becoming an important diagnostic tool due to the discovery of new phages and the increasing knowledge of understanding the specificity and functions of phage tail proteins.